Varón de 62 años con fenómeno de Raynaud

  1. Conde-Baena, Pablo 1
  2. Vargas-Hitos, José Antonio 1
  3. Mario Sabio, José 1
  4. NavarreteNavarrete, Nuria 1
  5. Zamora-Pasadas, Mónica 1
  6. Jiménez-Alonso, Juan 1
  1. 1 Hospital Universitario Virgen de las Nieves
    info

    Hospital Universitario Virgen de las Nieves

    Granada, España

    ROR https://ror.org/02f01mz90

Journal:
Actualidad médica

ISSN: 0365-7965

Year of publication: 2015

Tome: 100

Issue: 795

Pages: 98-101

Type: Article

DOI: 10.15568/AM.2015.795.CC02 DIALNET GOOGLE SCHOLAR lock_openDIGIBUG editor

More publications in: Actualidad médica

Sustainable development goals

Abstract

A 62-year-old male presented with a one month history of Raynaud’s phenomenon in both hands along with digital necrotic lesions and severe pain. The medical history and physical examination did not provide any additional information and nailfold capillaroscopy only showed escarce vasculature. Both laboratory (blood count, blood chemistry, thyroid hormones, tumor markers, serologies for hepatitis B and C, proteinogram, immunoglobulins, complement, cryoglobulins, autoimmunity tests) and imaging tests (echocardiography, thoracic and abdominal CT scan and a PET-CT) and even a biopsy of the ischemic lesions were normal or negative. However, the thrombophilia workup showed a heterozygous mutation in the genes of the methylenetetrahydrofolate reductase and the factor XII, and positivity for antiphospholipid antibodies (anti-beta2-glycoprotein). Once the diagnosis of antiphospholipid syndrome and genetic thrombophilia were made, treatment with oral vasodilators (prostacyclin and bosentan) and oral anticoagulants were started, which produced a satisfactory evolution of the ischemic lesions.

Bibliographic References

  • Abdallah M, Hamzaoui S, Larbi T, et al. Etiological profile of digital necrosis of the upper limbs: analysis of 25 cases. J Mal Vasc. 2010;35:12-6.
  • Cervera R, Espinosa G, Ramos-Casals M, Hernández-Rodríguez J, Cid MC, Ingelmo M. Fenómeno de Raynaud. En: Diagnóstico y tratamiento de las enfermedades autoinmunes sistémicas. España: 4ª Edición, Caduceo Multimedia, 2010; 307-18.
  • Herrick AL. Contemporary management of Raynaud’s phenomenon and digital ischemic complications. Curr Op in Rheumatology 2011; 23: 555-61.
  • Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498-509.
  • Wigley FM. Clinical practice: Raynaud´s phenomenon. N Engl J Med 2002; 347: 1001-8.
Data source: Dialnet